Alpha-Synuclein Continues to Enhance SNARE-Dependent Vesicle Docking at Exorbitant Concentrations

Overview

Journal Front Neurosci

Date 2019 Apr 6

PMID 30949020

Citations 24

Authors

Brenden J D Hawk

Ryan Khounlo

Yeon-Kyun Shin

Affiliations

Soon will be listed here.

Abstract

Recently, Parkinson's disease-associated α-synuclein (αS) has emerged as an important regulator for SNARE-dependent vesicle fusion. However, it is controversial if excessive accumulation of αS, even in the absence of aggregation, impairs neurotransmission. Here we use a single vesicle fusion assay with ms time resolution capable of dissecting the impact of αS on each step of membrane fusion. Unlike the previous results from various , cellular, and studies, we find that non-aggregated αS promotes vesicle merger even at exorbitant concentrations. The enhancement has been seen as much as 13 fold. Delving into the kinetics of the intermediate states for vesicle fusion reveals that αS stimulates vesicle docking without altering the dynamics of bilayer merger (lipid mixing). However, minute amounts of soluble aggregated species abolish SNARE-dependent bilayer merger completely. Thus, the results show that excessive accumulation of non-aggregated αS may not be toxic for neurotransmitter release.

Citing Articles

Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach.

Coles N, Elsheikh S, Quesnel A, Butler L, Jennings C, Tarzi C ACS Chem Neurosci. 2025; 16(4):687-698.

PMID: 39875340 PMC: 11843597. DOI: 10.1021/acschemneuro.4c00726.

Interplay between Copper, Phosphatidylserine, and α-Synuclein Suggests a Link between Copper Homeostasis and Synaptic Vesicle Cycling.

Teng X, Stefaniak E, Willison K, Ying L ACS Chem Neurosci. 2024; 15(15):2884-2896.

PMID: 39013013 PMC: 11311125. DOI: 10.1021/acschemneuro.4c00280.

From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein.

Nordengen K, Morland C Int J Mol Sci. 2024; 25(2).

PMID: 38256059 PMC: 10815905. DOI: 10.3390/ijms25020986.

α-Synuclein is the major platelet isoform but is dispensable for activation, secretion, and thrombosis.

Smith A, Joshi S, Chanzu H, Alfar H, Prakhya K, Whiteheart S Platelets. 2023; 34(1):2267147.

PMID: 37927048 PMC: 10629845. DOI: 10.1080/09537104.2023.2267147.

Single point mutations at the S129 residue of α-synuclein and their effect on structure, aggregation, and neurotoxicity.

Pandit E, Das L, Das A, Dolui S, Saha S, Pal U Front Chem. 2023; 11:1145877.

PMID: 37304685 PMC: 10250651. DOI: 10.3389/fchem.2023.1145877.

References

Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, AGOSTONI A . Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin Exp Immunol. 1999; 115(3):526-33. PMC: 1905247. DOI: 10.1046/j.1365-2249.1999.00835.x. View

Fernandez I, Arac D, Ubach J, Gerber S, Shin O, Gao Y . Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine. Neuron. 2002; 32(6):1057-69. DOI: 10.1016/s0896-6273(01)00548-7. View

Chapman E . Synaptotagmin: a Ca(2+) sensor that triggers exocytosis?. Nat Rev Mol Cell Biol. 2002; 3(7):498-508. DOI: 10.1038/nrm855. View

Seo J, Rah J, Choi S, Shin J, Min K, Kim H . Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J. 2002; 16(13):1826-8. DOI: 10.1096/fj.02-0041fje. View

Shimohama S, Sawada H, Kitamura Y, Taniguchi T . Disease model: Parkinson's disease. Trends Mol Med. 2003; 9(8):360-5. DOI: 10.1016/s1471-4914(03)00117-5. View

Fix M, Melia T, Jaiswal J, Rappoport J, You D, Sollner T . Imaging single membrane fusion events mediated by SNARE proteins. Proc Natl Acad Sci U S A. 2004; 101(19):7311-6. PMC: 409915. DOI: 10.1073/pnas.0401779101. View

Chandra S, Fornai F, Kwon H, Yazdani U, Atasoy D, Liu X . Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A. 2004; 101(41):14966-71. PMC: 522043. DOI: 10.1073/pnas.0406283101. View

Liu S, Ninan I, Antonova I, Battaglia F, Trinchese F, Narasanna A . alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J. 2004; 23(22):4506-16. PMC: 526467. DOI: 10.1038/sj.emboj.7600451. View

Yavich L, Tanila H, Vepsalainen S, Jakala P . Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci. 2004; 24(49):11165-70. PMC: 6730279. DOI: 10.1523/JNEUROSCI.2559-04.2004. View

10.

Liu T, Tucker W, Bhalla A, Chapman E, Weisshaar J . SNARE-driven, 25-millisecond vesicle fusion in vitro. Biophys J. 2005; 89(4):2458-72. PMC: 1366745. DOI: 10.1529/biophysj.105.062539. View

11.

Jahn R, Scheller R . SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol. 2006; 7(9):631-43. DOI: 10.1038/nrm2002. View

12.

Lee V, Trojanowski J . Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron. 2006; 52(1):33-8. DOI: 10.1016/j.neuron.2006.09.026. View

13.

Larsen K, Schmitz Y, Troyer M, Mosharov E, Dietrich P, Quazi A . Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci. 2006; 26(46):11915-22. PMC: 6674868. DOI: 10.1523/JNEUROSCI.3821-06.2006. View

14.

Yoon T, Okumus B, Zhang F, Shin Y, Ha T . Multiple intermediates in SNARE-induced membrane fusion. Proc Natl Acad Sci U S A. 2006; 103(52):19731-6. PMC: 1698870. DOI: 10.1073/pnas.0606032103. View

15.

Wu N, Joshi P, Cepeda C, Masliah E, Levine M . Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway. J Neurosci Res. 2009; 88(8):1764-76. PMC: 3707301. DOI: 10.1002/jnr.22327. View

16.

Karatekin E, Di Giovanni J, Iborra C, Coleman J, OShaughnessy B, Seagar M . A fast, single-vesicle fusion assay mimics physiological SNARE requirements. Proc Natl Acad Sci U S A. 2010; 107(8):3517-21. PMC: 2840481. DOI: 10.1073/pnas.0914723107. View

17.

Nemani V, Lu W, Berge V, Nakamura K, Onoa B, Lee M . Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010; 65(1):66-79. PMC: 3119527. DOI: 10.1016/j.neuron.2009.12.023. View

18.

Lee H, Yang Y, Su Z, Hyeon C, Lee T, Lee H . Dynamic Ca2+-dependent stimulation of vesicle fusion by membrane-anchored synaptotagmin 1. Science. 2010; 328(5979):760-3. PMC: 2994549. DOI: 10.1126/science.1187722. View

19.

Varkey J, Isas J, Mizuno N, Borch Jensen M, Bhatia V, Jao C . Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem. 2010; 285(42):32486-93. PMC: 2952250. DOI: 10.1074/jbc.M110.139576. View

20.

Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton M, Sudhof T . Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010; 329(5999):1663-7. PMC: 3235365. DOI: 10.1126/science.1195227. View